J-PAL North America and Results for America announce 18 collaborations with state and local governments
Organizations will support government agencies in using evidence to advance economic mobility and racial equity in the wake of Covid-19.
Organizations will support government agencies in using evidence to advance economic mobility and racial equity in the wake of Covid-19.
Richard Binzel describes how asteroid dirt and dust delivered by OSIRIS-Rex, with help from MIT, may reveal clues to the solar system’s origins.
Department of Brain and Cognitive Sciences faculty members Ev Fedorenko, Ted Gibson, and Roger Levy believe they can answer a fundamental question: What is the purpose of language?
Center for International Studies Global Seed Funds program fosters collaboration and innovation.
MIT Plasma Science and Fusion Center will receive DoE support to improve access to fusion data and increase workforce diversity.
For Interphase EDGE/x participants, a life-sized Barbie-themed TARDIS prompts reflections on social norms.
The MIT and Accenture Convergence Initiative for Industry and Technology selects three new research projects to support.
Mens, Manus and Machina (M3S) will design technology, training programs, and institutions for successful human-machine collaboration.
“The Laboratory of Change” is the theme for the 18th International Architecture Exhibition.
The MIT Schwarzman College of Computing awards seed grants to seven interdisciplinary projects exploring AI-augmented management.
For MIT CSHub postdoc Miaomiao Zhang, communicating effectively is perhaps the most important part of research.
Fusion Undergraduate Scholars (FUSars) program offers students in-depth research opportunities in fusion science and energy.
With support from 322 libraries — a 33 percent increase in participation over its first year — the D2O publishing model will include over 160 scholarly monographs and edited collections by the end of 2023.
In a visit to MIT, the educator and author led a lively and inspiring Q&A with students.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.